insights_auto
Outlook: 92.9% bullish·0.0% bearish
Go to analysischevron_right
HALO:NASDAQ
Halozyme Therapeutics, Inc.
$122.50
arrow_upward
+0.54%(+0.66) 1D
$123.60
arrow_upward
+0.90% (+1.10)bedtimeAfter hours
Closed: Oct 19, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 7 analysts giving stock ratings to HALO in the past 3 months
Buy
Buy
5
Hold
2
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for HALO in the last 3 months.
Highest
Current $122.50
$130.00 (+6.12%)
Average
$105.86 (-13.58%)
Lowest
$78.00 (-36.33%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Mitchell Kapoor H.C. Wainwright | Buy | Reiterated | $130.00 | +6.1% | 10/16/2026 |
Brendan Smith TD Cowen | Buy | Reiterated | $130.00 | +6.1% | 10/13/2026 |
Jessica Fye J.P. Morgan | Hold | Reiterated | $78.00 | -36.3% | 10/08/2026 |
David Risinger Leerink Partners | Buy | Maintained | $110.00 | -10.2% | 10/07/2026 |
Sean Laaman Morgan Stanley | Buy | Reiterated | $105.00 | -14.3% | 08/07/2026 |
Jason Butler Citizens JMP | Buy | Maintained | $93.00 | -24.1% | 08/07/2026 |
Mohit Bansal Wells Fargo | Hold | Reiterated | $95.00 | -22.4% | 08/07/2026 |
Corinne Johnson Goldman Sachs | Sell | Maintained | $57.00 | -53.5% | 06/14/2026 |
Unknown Analyst J.P. Morgan | Hold | Maintained | $70.00 | -42.9% | 05/20/2026 |
Robert Wasserman Benchmark Co. | Buy | Maintained | $90.00 | -26.5% | 02/19/2026 |